1 yıllık getiri (CAGR)
39.50%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
256.03
-6.08 (-2.30%)
HealthcareDrug Manufacturers - General
Loading...
3 yıllık getiri (CAGR)
17.61%
5 yıllık getiri (CAGR)
9.43%
10 yıllık getiri (CAGR)
8.08%
Adobe 2026 3. Çeyrek – Fiyatı piyasa algısı mı belirliyor?
Daha fazla okuPiyasa değeri
623.34B
Fiyat/Satış
6.37
Ent değeri
719.01B
Fiyat/Defter
7.34
DIV kazancı
2.07%
Büyüme yılları
58
DIV büyümesi
5.25%
FCF ödemesi
95.35%
Trailing P/E
29.63
PEG
4.63
İleri P/E
20.82
EPS büyümesi
14.90%
İş anlayişi
Temel Analizin Anlamı ve Metodolojisi (2025)
Daha fazla okuSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...